Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women
who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or …

Peripartum cardiomyopathy (PPCM) is characterized by the development of systolic heart
failure in the last month of pregnancy or within the first 5 months postpartum. The disease …

Peripartum cardiomyopathy (PPCM) is a potentially fatal form of idiopathic heart failure with
variable prevalence across different countries and ethnic groups. The cause of PPCM is …

Objectives: This study explored the association of vascular hormones with myocardial
recovery and clinical outcomes in peripartum cardiomyopathy (PPCM). Background: PPCM …

OBJECTIVE: The purpose of this study was to determine whether fetal programming of adult
blood pressure is altered in a previously characterized mouse model of preeclampsia that …

Cardiovascular diseases are a major cause of complications in pregnancy worldwide, and
the number of patients who develop cardiac problems during pregnancy is increasing …

Despite intense investigation, mechanisms that facilitate the emergence of the pre-
eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension …

Peripartum cardiomyopathy (PPCM), according to the actual definition proposed by the
Study Group on PPCM of the Heart Failure Association of the European Society of …

Peripartum cardiomyopathy (PPCM) is a life-threatening cardiomyopathy characterized by
acute or slow progression of left ventricular (LV) systolic dysfunction (LV ejection fraction of< …

Background: Peripartum cardiomyopathy (PPCM) occurs in≈ 1: 2000 deliveries in the
United States and worldwide. The genetic underpinnings of PPCM remain poorly defined …